{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:23:32Z","timestamp":1789521812099,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT \\u2013 169095"],"award-info":[{"award-number":["PJT \\u2013 169095"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CGV-186893"],"award-info":[{"award-number":["CGV-186893"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-195804"],"award-info":[{"award-number":["PJT-195804"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Fondation canadienne pour l'innovation","doi-asserted-by":"publisher","award":["229792"],"award-info":[{"award-number":["229792"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","award":["288558"],"award-info":[{"award-number":["288558"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000263","name":"Parkinson Society Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009307","name":"Parkinson Society Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009307","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nbd.2026.107485","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:07:40Z","timestamp":1781208460000},"page":"107485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease"],"prefix":"10.1016","volume":"227","author":[{"given":"Esther","family":"del Cid-Pellitero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Goiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid A.M.","family":"Al-Azzawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan C.","family":"Karpilovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jace","family":"Jones-Tabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas J.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Larroquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shlaifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogitha","family":"Thattikota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Trempe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Fon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.nbd.2026.107485_bb0005","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-Synuclein in familial and sporadic Lewy body disease*","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Pt B","key":"10.1016\/j.nbd.2026.107485_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","article-title":"Post-translational modification of \u03b1-synuclein in Parkinson\u2019s disease","volume":"1628","author":"Barrett","year":"2015","journal-title":"Brain Res."},{"issue":"7362","key":"10.1016\/j.nbd.2026.107485_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.nbd.2026.107485_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103727","article-title":"N-alpha-acetylation of \u03b1-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation","volume":"9","author":"Bartels","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.nbd.2026.107485_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111102","article-title":"Rapid macropinocytic transfer of \u03b1-synuclein to lysosomes","volume":"40","author":"Bayati","year":"2022","journal-title":"Cell Rep."},{"issue":"17","key":"10.1016\/j.nbd.2026.107485_bb0030","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/acs.biochem.2c00104","article-title":"N-terminal acetylation of \u03b1-synuclein slows down its aggregation process and alters the morphology of the resulting aggregates","volume":"61","author":"Bell","year":"2022","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167825","article-title":"Effects of N-terminal acetylation on the aggregation of disease-related \u03b1-synuclein variants","volume":"435","author":"Bell","year":"2023","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40478-015-0254-7","article-title":"Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein","volume":"3","author":"Bernis","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/j.nbd.2026.107485_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000318","article-title":"Identification of N-linked glycans as specific mediators of neuronal uptake of acetylated \u03b1-Synuclein","volume":"17","author":"Birol","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.nbd.2026.107485_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.01021","article-title":"A Meta-analysis of \u03b1-Synuclein multiplication in familial parkinsonism","volume":"9","author":"Book","year":"2018","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2026.107485_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.nbd.2026.107485_bb0060","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nbd.2026.107485_bb0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ejn.14286","article-title":"Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene","volume":"49","author":"Chen","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2026.107485_bb0070","series-title":"Generation of Dopaminergic or Cortical Neurons from Neuronal Progenitors","author":"Chen","year":"2019"},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","article-title":"LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread","volume":"17","author":"Chen","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.nbd.2026.107485_bb0080","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","article-title":"Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid","volume":"18","author":"Concha-Marambio","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2026.107485_bb0085","series-title":"Quality control characterization of \u03b1-Synuclein preformed fibrils (PFFs)","first-page":"1","volume":"3","author":"Del Cid","year":"2019"},{"key":"10.1016\/j.nbd.2026.107485_bb0090","first-page":"1","article-title":"Midbrain organoids with an <em>SNCA<\/em> gene triplication display dopamine-dependent alterations in network activity","author":"Deyab","year":"2025","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.nbd.2026.107485_bb0095","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1074\/jbc.M113.512459","article-title":"N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound \u03b1-synuclein and increases its affinity for physiological membranes","volume":"289","author":"Dikiy","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.nbd.2026.107485_bb0100","doi-asserted-by":"crossref","first-page":"15345","DOI":"10.1074\/jbc.M111.318949","article-title":"\u03b1-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer","volume":"287","author":"Fauvet","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.nbd.2026.107485_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071083","article-title":"\u03b1-Synuclein preformed fibrils bind to \u03b2-Neurexins and impair \u03b2-Neurexin-mediated presynaptic organization","volume":"12","author":"Feller","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.nbd.2026.107485_bb0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","article-title":"Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC","volume":"6","author":"Groveman","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2026.107485_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.656426","article-title":"Lymphocyte activation gene 3 (Lag3) contributes to \u03b1-synucleinopathy in \u03b1-synuclein transgenic mice","volume":"15","author":"Gu","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2026.107485_bb0125","doi-asserted-by":"crossref","first-page":"134316","DOI":"10.1016\/j.neulet.2019.134316","article-title":"\u03b1-Synuclein pathology in Parkinson\u2019s disease and related \u03b1-synucleinopathies","volume":"709","author":"Henderson","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00401-025-02957-5","article-title":"Co-infection with two \u03b1-synuclein strains reveals novel synergistic interactions","volume":"150","author":"Holec","year":"2025","journal-title":"Acta Neuropathol."},{"issue":"33","key":"10.1016\/j.nbd.2026.107485_bb0135","doi-asserted-by":"crossref","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","article-title":"Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds","volume":"110","author":"Holmes","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.nbd.2026.107485_bb0140","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41419-022-05330-6","article-title":"Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications","volume":"13","author":"Iannielli","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0145","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1038\/s41598-017-08720-5","article-title":"Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type","volume":"7","author":"Ihse","year":"2017","journal-title":"Sci. Rep."},{"issue":"40","key":"10.1016\/j.nbd.2026.107485_bb0150","doi-asserted-by":"crossref","first-page":"21110","DOI":"10.1074\/jbc.M116.726612","article-title":"The impact of N-terminal acetylation of \u03b1-Synuclein on phospholipid membrane binding and fibril structure","volume":"291","author":"Iyer","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.nbd.2026.107485_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158338","article-title":"The prion-like spreading of alpha-synuclein in Parkinson\u2019s disease: update on models and hypotheses","volume":"22","author":"Jan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.nbd.2026.107485_bb0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/sctm.18-0180","article-title":"Stimulation of L-type calcium channels increases tyrosine hydroxylase and dopamine in ventral midbrain cells induced from somatic cells","volume":"9","author":"Jefri","year":"2020","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13024-024-00779-9","article-title":"The Parkinson\u2019s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons","volume":"19","author":"Jones-Tabah","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"7","key":"10.1016\/j.nbd.2026.107485_bb0170","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/pro.2088","article-title":"N-terminal acetylation of \u03b1-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer","volume":"21","author":"Kang","year":"2012","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0175","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/srep05797","article-title":"Quantitative measurement of intact alpha-Synuclein Proteoforms from post-mortem control and Parkinson\u2019s disease brain tissue by intact protein mass spectrometry","volume":"4","author":"Kellie","year":"2014","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.nbd.2026.107485_bb0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.nbd.2026.107485_bb0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41380-019-0608-9","article-title":"Systemic \u03b1-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson\u2019s disease","volume":"26","author":"Kuan","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JPD-2011-11004","article-title":"Signs of degeneration in 12\u201322-year old grafts of mesencephalic dopamine neurons in patients with Parkinson\u2019s disease","volume":"1","author":"Kurowska","year":"2011","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","article-title":"\u03b1-Synuclein strains target distinct brain regions and cell types","volume":"23","author":"Lau","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"6109","key":"10.1016\/j.nbd.2026.107485_bb0200","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.nbd.2026.107485_bb0205","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1021\/bi300642h","article-title":"Impact of N-terminal acetylation of \u03b1-Synuclein on its random coil and lipid binding properties","volume":"51","author":"Maltsev","year":"2012","journal-title":"Biochemistry"},{"issue":"6307","key":"10.1016\/j.nbd.2026.107485_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah3374","article-title":"Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3","volume":"353","author":"Mao","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0215","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-024-49016-3","article-title":"Aplp1 interacts with Lag3 to facilitate transmission of pathologic \u03b1-synuclein","volume":"15","author":"Mao","year":"2024","journal-title":"Nat. Commun."},{"issue":"Pt 4","key":"10.1016\/j.nbd.2026.107485_bb0220","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nbd.2026.107485_bb0225","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab223","article-title":"Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy","volume":"3","author":"Mohamed","year":"2021","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0230","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41531-025-01080-2","article-title":"Impact of \u03b1-synuclein fibril structure on seeding activity in experimental models of Parkinson\u2019s disease","volume":"11","author":"Ohira","year":"2025","journal-title":"Npj Parkinsons Dis."},{"key":"10.1016\/j.nbd.2026.107485_bb0235","series-title":"Progress in Brain Research","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","article-title":"Chapter 7 - Role of post-translational modifications in modulating the structure, function and toxicity of \u03b1-synuclein: Implications for Parkinson\u2019s disease pathogenesis and therapies","volume":"183","author":"Oueslati","year":"2010"},{"key":"10.1016\/j.nbd.2026.107485_bb0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","article-title":"Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration","volume":"82","author":"Paumier","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.nbd.2026.107485_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198715","article-title":"pTSara-NatB, an improved N-terminal acetylation system for recombinant protein expression in E. Coli","volume":"13","author":"Rovere","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0250","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41598-019-57023-4","article-title":"The N-terminal acetylation of \u03b1-synuclein changes the affinity for lipid membranes but not the structural properties of the bound state","volume":"10","author":"Runfola","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.nbd.2026.107485_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178576","article-title":"The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of \u03b1-Synuclein","volume":"12","author":"Ruzafa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2026.107485_bb0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fnagi.2020.00167","article-title":"SUMOylation in \u03b1-Synuclein homeostasis and pathology","volume":"12","author":"Savyon","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"52","key":"10.1016\/j.nbd.2026.107485_bb0265","doi-asserted-by":"crossref","first-page":"18076","DOI":"10.1074\/jbc.RA120.015319","article-title":"\u03b1-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate","volume":"295","author":"Schechter","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"7980","key":"10.1016\/j.nbd.2026.107485_bb0270","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-023-06437-2","article-title":"Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids","volume":"621","author":"Scheres","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.nbd.2026.107485_bb0275","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1074\/mcp.R113.032730","article-title":"Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies","volume":"12","author":"Schmid","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"issue":"18","key":"10.1016\/j.nbd.2026.107485_bb0280","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1021\/ja2009554","article-title":"Allostery in a disordered protein: oxidative modifications to \u03b1-synuclein act distally to regulate membrane binding","volume":"133","author":"Sevcsik","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.nbd.2026.107485_bb0285","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"6645","key":"10.1016\/j.nbd.2026.107485_bb0290","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.nbd.2026.107485_bb0295","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1016\/j.bpj.2024.09.019","article-title":"Folding of N-terminally acetylated \u03b1-synuclein upon interaction with lipid membranes","volume":"123","author":"Tang","year":"2024","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0300","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s42003-025-08786-2","article-title":"Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of \u03b1-synuclein fibrils","volume":"8","author":"Vanderperre","year":"2025","journal-title":"Commun. Biol."},{"issue":"35","key":"10.1016\/j.nbd.2026.107485_bb0305","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1021\/acs.biochem.9b00629","article-title":"N-terminal acetylation affects \u03b1-synuclein fibril polymorphism","volume":"58","author":"Watson","year":"2019","journal-title":"Biochemistry"},{"issue":"6736","key":"10.1016\/j.nbd.2026.107485_bb0310","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1126\/science.adp3645","article-title":"Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson\u2019s disease","volume":"387","author":"Wu","year":"2025","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nbd.2026.107485_bb0315","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.160696","article-title":"Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation","volume":"4","author":"Xue","year":"2017","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.nbd.2026.107485_bb0320","first-page":"1","article-title":"Neuronal LAG3 facilitates pathogenic \u03b1-synuclein neuron-to-neuron propagation","author":"Yang","year":"2025","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.nbd.2026.107485_bb0325","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","article-title":"Post-translational modifications of soluble \u03b1-synuclein regulate the amplification of pathological \u03b1-synuclein","volume":"26","author":"Zhang","year":"2023","journal-title":"Nat. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:55:27Z","timestamp":1787583327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126002305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":65,"alternative-id":["S0969996126002305"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107485","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107485"}}